(MedPage Today) — The FDA approved Cleveland Diagnostics’ blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
Dubbed IsoPSA, the in vitro diagnostic kit is indicated for men ages 50…
Source link : https://www.medpagetoday.com/urology/prostatecancer/118778
Author :
Publish date : 2025-12-01 22:21:00
Copyright for syndicated content belongs to the linked Source.
